Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis

Anti‐tumor necrosis factor (anti‐TNF) drugs are often prescribed for the treatment of rheumatoid arthritis (RA) and other immune‐mediated inflammatory diseases. Although this treatment has been shown to be effective in many patients, up to 40% of patients do not achieve disease control. Drug concent...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Stéphane, Marotte, Hubert, Kavanaugh, Arthur, Goupille, Philippe, Kvien, Tore K., de Longueville, Marc, Mulleman, Denis, Sandborn, William J., Vande Casteele, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359948/
https://www.ncbi.nlm.nih.gov/pubmed/32100960
http://dx.doi.org/10.1111/cts.12760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359948/
https://www.ncbi.nlm.nih.gov/pubmed/32100960
http://dx.doi.org/10.1111/cts.12760

Ejemplares similares